Literature DB >> 8568145

Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions.

L M Schwiebert1, L A Beck, C Stellato, C A Bickel, B S Bochner, R P Schleimer, L A Schwiebert.   

Abstract

We believe that there are the following four classes of glucocorticoid-sensitive cytokines that are involved in cell recruitment: (1) those that activate endothelium nonspecifically; (2) those that activate endothelium specifically; (3) those that activate, prime, and prolong the survival of eosinophils; and (4) those that stimulate movement of cells up into the epithelium. Glucocorticoids inhibit the generation of these cytokines and thereby prevent several different aspects of inflammation, including the activation and recruitment of inflammatory cells (eosinophils, basophils, and lymphocytes) and the release of inflammatory mediators. We believe such pleiotropic actions account for the efficacy and widespread use of glucocorticoids in the treatment of asthma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8568145     DOI: 10.1016/s0091-6749(96)80214-4

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  25 in total

Review 1.  Pharmacologic management of the hospitalized pediatric asthma patient.

Authors:  K A Hardin; H J Kallas; R J McDonald
Journal:  Clin Rev Allergy Immunol       Date:  2001-06       Impact factor: 8.667

2.  Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease.

Authors:  Howard A Kader; Velizar T Tchernev; Ebenezer Satyaraj; Serguei Lejnine; Gregory Kotler; Stephen F Kingsmore; Dhavalkumar D Patel
Journal:  Am J Gastroenterol       Date:  2005-02       Impact factor: 10.864

Review 3.  Recent developments in the treatment of otitis media with effusion.

Authors:  Ellen M Mandel; Margaretha L Casselbrant
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Delayed addition of glucocorticoids selectively suppresses cytokine production in stimulated human whole blood.

Authors:  Devin L Horton; Daniel G Remick
Journal:  Clin Vaccine Immunol       Date:  2010-05-05

Review 5.  Management of Radiation Proctitis.

Authors:  Lameese Tabaja; Shafik M Sidani
Journal:  Dig Dis Sci       Date:  2018-09       Impact factor: 3.199

6.  Dexamethasone inhibits TRAIL- and anti-cancer drugs-induced cell death in A549 cells through inducing NF-kappaB-independent cIAP2 expression.

Authors:  Youn Seup Kim; Jae Seuk Park; Young Koo Jee; Kye Young Lee
Journal:  Cancer Res Treat       Date:  2004-10-31       Impact factor: 4.679

7.  Cytokine release and its modulation by dexamethasone in whole blood following exercise.

Authors:  H H Smits; K Grünberg; R H Derijk; P J Sterk; P S Hiemstra
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

8.  Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines.

Authors:  C Stellato; P Collins; P D Ponath; D Soler; W Newman; G La Rosa; H Li; J White; L M Schwiebert; C Bickel; M Liu; B S Bochner; T Williams; R P Schleimer
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

9.  Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line.

Authors:  S P Sanders; E S Siekierski; J D Porter; S M Richards; D Proud
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

10.  Eosinophil survival and apoptosis in health and disease.

Authors:  Yong Mean Park; Bruce S Bochner
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.